NCT00002588View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 1994

Primary Completion Date

July 31, 2000

Study Completion Date

January 31, 2001

Conditions
Leukemia
Interventions
DRUG

etoposide

DRUG

topotecan hydrochloride

Trial Locations (1)

44106-5065

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Case Comprehensive Cancer Center

OTHER

NCT00002588 - Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia | Biotech Hunter | Biotech Hunter